Resultados de la búsqueda 121-130 of 10784 for Vitiligo

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  2. Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet. Dec. 14, 2021 . VID-20522540.

  3. Carcinoma hepatocelular

    Hepatocellular carcinoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1514. Accessed July 25, 2025.

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

  6. Otorrinolaringología (oído, nariz y garganta) y cirugía de cabeza y cuello - Ensayos clínicos - Mayo Clinic

    Obtén más información sobre los ensayos clínicos que se llevan a cabo en Mayo Clinic para lograr avances en el tratamiento y en los resultados para personas ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...